The strongest evidence comes from childhood: low diversity predicts more infections and allergies
The most direct evidence linking gut microbiome diversity to long-term immune health comes from studies in children. In a longitudinal study of 300 children aged 1–5 years, those who received broad-spectrum antibiotics experienced significant reductions in gut microbiota diversity and later showed higher rates of respiratory and gastrointestinal infections, as well as more allergic diseases and autoimmune conditions [2]. The effect was most pronounced in the youngest children (1–2 years old), whose immune systems are still developing. This suggests that early-life disruptions to microbiome diversity can have lasting consequences for immune function.
Another large study of 2,004 children found that those exposed to socioeconomic stress (such as financial difficulties or low maternal education) had lower gut bacterial diversity at age 10, and this was linked to changes in predicted immune-related pathways, including tryptophan biosynthesis, which is important for immune regulation [5]. The study also showed that poor diet and higher body mass index partly explained the link, meaning that diversity loss doesn't act alone—it works together with other factors to shape immune outcomes.
How diversity shapes immunity: the mechanisms behind the prediction
Gut microbiome diversity isn't just a number—it reflects a community of microbes that produce molecules directly influencing the immune system. A diverse microbiome produces a wider range of short-chain fatty acids (like butyrate) and other metabolites that help regulate inflammation and support the gut barrier [1][4]. For example, in a mouse study, supplementing with Bifidobacterium infantis and a prebiotic (2'-fucosyllactose) in early life increased gut microbial diversity, boosted anti-inflammatory molecules like IL-10, and reduced pro-inflammatory cytokines like TNF-α, with effects that persisted into adulthood [7]. This shows that a richer microbial community can actively train the immune system to respond appropriately.
The immune system also 'learns' from the microbiome through antibody transfer. A study in mice found that maternal gut microbiome-induced IgG antibodies are passed to offspring through milk, directly protecting against intestinal infections and shaping the baby's own gut microbiome and immune cell development [6]. This means that a mother's microbiome diversity can influence her child's immune health even before the child's own microbiome is fully established.
The gap between best-case and typical-case evidence: diversity is a predictor, not a guarantee
While the link between microbiome diversity and immune health is clear in controlled studies, real-world evidence is more mixed. The largest study here (2,004 children) found that overall early-life stress did not predict microbiome diversity—only the specific domain of socioeconomic stress did [5]. This suggests that diversity is a sensitive marker, but it's not a universal crystal ball; other factors like diet, exercise, and genetics can override its effects.
Moreover, the microbiome is remarkably stable after age 3, but it can still be reshaped by diet and lifestyle [1]. In a study of children and adolescents, an unbalanced microbiome with low diversity and poor connectivity, combined with a low-fiber diet and reduced physical activity, predicted the development of obesity over four years [3]. This means that diversity alone is not enough—it's the interaction between the microbiome and behavior that determines long-term health outcomes. So while a diverse gut microbiome is a strong predictor of better immune health, especially in early life, it is not a standalone guarantee; maintaining it requires ongoing attention to diet, stress, and antibiotic use.
About These Sources
This answer is built on 7 peer-reviewed studies — published from 2022 to 2026, 4 from 2024 or later, 6 in Q1 journals, collectively cited 92 times — selected as the most relevant from 10 studies that passed quality screening, drawn from 80 papers retrieved from a database of over 500 million.
Sources used in this answer
The Gut Microbiome: A Primer for the Clinician
This primer explains that gut microbiome diversity (richness and evenness) is a key marker of health, and that dysbiosis (low diversity) is linked to diseases like C. difficile infection and inflammatory bowel disease. It notes that after age 3, the colon microbiome is remarkably stable.
The Impact of Antibiotic Use on Immune Function and Gut Microbiota in Children Aged 1–5 Years
In a longitudinal study of 300 children aged 1–5 years, antibiotic use caused significant reductions in gut microbiota diversity and altered immune cell populations, with broad-spectrum antibiotics causing more severe and prolonged disruptions, leading to higher rates of infections, allergies, and autoimmune conditions.
Disrupted gut microbiome networks and unhealthy behaviors predict metabolic dysfunction in children and adolescents in the long term
In a cohort of 218 children and adolescents followed for 4 years, an unbalanced gut microbiome with low diversity and poor connectivity, combined with low-fiber diet and reduced physical activity, predicted the development of obesity.
The molecular interplay between the gut microbiome and circadian rhythms: an integrated review
This review describes bidirectional communication between the gut microbiome and circadian rhythms, noting that microbial metabolites like butyrate influence immune function and that disruption of this dialogue (chronodisruption) predisposes to metabolic syndrome, IBD, and cancer.
Early-life stress and the gut microbiome: A comprehensive population-based investigation
In a population-based study of 2,004 children, socioeconomic stress (but not overall early-life stress) was associated with lower gut microbiome alpha-diversity and altered predicted functional pathways (e.g., tryptophan biosynthesis), partly mediated by diet and BMI.
Maternal gut microbiome–induced IgG regulates neonatal gut microbiome and immunity
In mice, maternal gut microbiome-induced IgG antibodies transferred through milk protected neonates against Citrobacter rodentium infection and shaped the development of the neonatal gut microbiome and immune cells, with effects persisting into adulthood.
Bifidobacterium infantis and 2′-fucosyllactose supplementation in early life may have potential long-term benefits on gut microbiota, intestinal development, and immune function in mice
In neonatal mice, early-life supplementation with Bifidobacterium infantis and/or 2'-fucosyllactose persistently altered gut microbiota, increased intestinal development markers (Ki67, MUC2), and modulated immune function (increased IL-10, decreased TNF-α), with some effects lasting into adulthood.